LeddarTech 10-Q 27 Nov 23 2023 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Nov. 28, 2023
Document Information Line Items
Entity Registrant Name	PROSPECTOR CAPITAL CORP.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001825473
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-39854
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	1250 Prospect Street
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	La Jolla
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92037
City Area Code	(650)
Local Phone Number	396-7700
Entity Interactive Data Current	Yes
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant
Document Information Line Items
Trading Symbol	PRSRU
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant
Security Exchange Name	NASDAQ
Class A ordinary shares, par value $0.0001 per share
Document Information Line Items
Trading Symbol	PRSR
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Security Exchange Name	NASDAQ
Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Document Information Line Items
Trading Symbol	PRSRW
Title of 12(b) Security	Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Security Exchange Name	NASDAQ
Class A Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		2,194,056
Class B Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		8,125,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 26,121	$ 18,401
Prepaid expenses	69,583
Total Current Assets	95,704	18,401
Investments held in Trust Account	23,750,947	329,783,734
TOTAL ASSETS	23,846,651	329,802,135
Current liabilities
Accrued expenses	5,660,531	787,909
Total Current Liabilities	5,660,730	788,108
Warrant liability	800,000
Total Liabilities	7,699,353	945,108
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 2,194,056 and 32,500,000 shares at $10.83 and $10.15 per share redemption value at September 30, 2023 and December 31, 2022, respectively	23,750,947	329,783,734
Shareholders’ Deficit
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital
Accumulated deficit	(7,604,462)	(927,520)
Total Shareholders’ Deficit	(7,603,649)	(926,707)
TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT	23,846,651	329,802,135
Class A Ordinary Shares
Shareholders’ Deficit
Ordinary shares
Class B Ordinary Shares
Shareholders’ Deficit
Ordinary shares	813	813
Related Party
Current liabilities
Due to Sponsor	199	199
Convertible Promissory Note – Related Party	$ 1,238,623	$ 157,000

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Preference shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized	1,000,000	1,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares
Class A ordinary shares subject to possible redemption	2,194,056	32,500,000
Class A ordinary shares subject to per share redemption value (in Dollars per share)	$ 10.83	$ 10.15
Class A ordinary shares subject to possible redemption par value (in Dollars)	$ 0.0001	$ 0.0001
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	200,000,000	200,000,000
Ordinary shares, shares issued
Ordinary shares, shares outstanding
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	20,000,000	20,000,000
Ordinary shares, shares issued	8,125,000	8,125,000
Ordinary shares, shares outstanding	8,125,000	8,125,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
General and administrative expenses	$ 1,035,704	$ 196,521	$ 5,876,943	$ 690,133
Loss from operations	(1,035,704)	(196,521)	(5,876,943)	(690,133)
Other income:
Change in fair value of warrant liability	1,120,000		320,000
Interest earned on investments held in Trust Account	288,519	1,479,369	1,587,561	1,958,356
Total other income	1,408,519	1,479,369	1,907,561	1,958,356
Net income (loss)	$ 372,815	$ 1,282,848	$ (3,969,382)	$ 1,268,223
Class A Ordinary Shares
Other income:
Weighted average shares outstanding (in Shares)	2,194,056	32,500,000	4,858,315	32,500,000
Basic net (loss) income per share (in Dollars per share)	$ 0.04	$ 0.03	$ (0.31)	$ 0.03
Class B Ordinary Shares
Other income:
Weighted average shares outstanding (in Shares)	8,125,000	8,125,000	8,125,000	8,125,000
Basic net (loss) income per share (in Dollars per share)	$ 0.04	$ 0.03	$ (0.31)	$ 0.03

Condensed Statements of Opera_2

Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Class A Ordinary Shares
Weighted average shares outstanding	2,194,056	32,500,000	4,858,315	32,500,000
Diluted net income (loss) per share	$ 0.04	$ 0.03	$ (0.31)	$ 0.03
Class B Ordinary Shares
Weighted average shares outstanding	8,125,000	8,125,000	8,125,000	8,125,000
Diluted net income (loss) per share	$ 0.04	$ 0.03	$ (0.31)	$ 0.03

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)	Class A Ordinary Shares	Class B Ordinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021		$ 813		$ (11,282,591)	$ (11,281,778)
Balance (in Shares) at Dec. 31, 2021		8,125,000
Net income loss (as restated)				(274,560)	(274,560)
Balance at Mar. 31, 2022		$ 813		(11,557,151)	(11,556,338)
Balance (in Shares) at Mar. 31, 2022		8,125,000
Balance at Dec. 31, 2021		$ 813		(11,282,591)	(11,281,778)
Balance (in Shares) at Dec. 31, 2021		8,125,000
Net income loss (as restated)					1,268,223
Balance at Sep. 30, 2022		$ 813		(617,017)	(616,204)
Balance (in Shares) at Sep. 30, 2022		8,125,000
Balance at Mar. 31, 2022		$ 813		(11,557,151)	(11,556,338)
Balance (in Shares) at Mar. 31, 2022		8,125,000
Accretion of Class A ordinary shares to redemption amount				10,876,720	10,876,720
Net income loss (as restated)				259,935	259,935
Balance at Jun. 30, 2022		$ 813		(420,496)	(419,683)
Balance (in Shares) at Jun. 30, 2022		8,125,000
Accretion of Class A ordinary shares to redemption amount				(1,479,369)	(1,479,369)
Net income loss (as restated)				1,282,848	1,282,848
Balance at Sep. 30, 2022		$ 813		(617,017)	(616,204)
Balance (in Shares) at Sep. 30, 2022		8,125,000
Balance at Dec. 31, 2022		$ 813		(927,520)	(926,707)
Balance (in Shares) at Dec. 31, 2022		8,125,000
Accretion of Class A ordinary shares to redemption amount				(1,025,595)	(1,025,595)
Initial Classification of Warrant Liabilities (as restated)				(1,120,000)	(1,120,000)
Net income loss (as restated)				(480,390)	(480,390)
Balance at Mar. 31, 2023		$ 813		(3,553,505)	(3,552,692)
Balance (in Shares) at Mar. 31, 2023		8,125,000
Balance at Dec. 31, 2022		$ 813		(927,520)	(926,707)
Balance (in Shares) at Dec. 31, 2022		8,125,000
Balance at Jun. 30, 2023		$ 813		(7,688,759)	(7,687,946)
Balance (in Shares) at Jun. 30, 2023		8,125,000
Balance at Dec. 31, 2022		$ 813		(927,520)	(926,707)
Balance (in Shares) at Dec. 31, 2022		8,125,000
Net income loss (as restated)					(3,969,382)
Balance at Sep. 30, 2023		$ 813		(7,604,462)	(7,603,649)
Balance (in Shares) at Sep. 30, 2023		8,125,000
Balance at Mar. 31, 2023		$ 813		(3,553,505)	(3,552,692)
Balance (in Shares) at Mar. 31, 2023		8,125,000
Accretion of Class A ordinary shares to redemption amount				(273,447)	(273,447)
Net income loss (as restated)				(3,861,807)	(3,861,807)
Balance at Jun. 30, 2023		$ 813		(7,688,759)	(7,687,946)
Balance (in Shares) at Jun. 30, 2023		8,125,000
Accretion of Class A ordinary shares to redemption amount				(288,518)	(288,518)
Net income loss (as restated)				372,815	372,815
Balance at Sep. 30, 2023		$ 813		$ (7,604,462)	$ (7,603,649)
Balance (in Shares) at Sep. 30, 2023		8,125,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities:
Net (loss) income	$ (3,969,382)	$ 1,268,223
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Interest earned on investments held in Trust Account	(1,587,561)	(1,958,356)
Change in fair value of warrant liability	(320,000)
Changes in operating assets and liabilities:
Prepaid expenses	(69,582)	(120,500)
Accrued expenses	4,872,622	46,603
Net cash used in operating activities	(1,073,903)	(764,030)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account in connection with redemption	307,620,347
Net cash provided by investing activities	307,620,347
Cash Flows from Financing Activities:
Proceeds from Convertible Promissory Note – Related Party	1,081,623	157,000
Repayment of advances from related party		(70,000)
Advance from Sponsor		70,000
Redemption of ordinary shares	(307,620,347)
Net cash (used in) provided by financing activities	(306,538,724)	157,000
Net Change in Cash	7,720	(607,030)
Cash – Beginning of period	18,401	627,632
Cash – Ending of period	26,121	20,602
Non-cash investing and financing activities:
Initial classification of Warrant Liability	$ 1,120,000

Description of Organization and

Description of Organization and Business Operations	9 Months Ended
	Sep. 30, 2023
Description of Organization and Business Operations [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Prospector Capital Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on September 18, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2023, the Company had not commenced any operations. All activity for the period from September 18, 2020 (inception) through September 30, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generates any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on January 7, 2021. On January 12, 2021, the Company consummated the Initial Public Offering of 32,500,000 units (the “Units”), which includes the partial exercise by the underwriter of its over-allotment option in the amount of 2,500,000 Units, at $10.00 per Unit, generating gross proceeds of $325,000,000 which is described in Note 4. Transaction costs amounted to $18,391,778, consisting of $6,500,000 of underwriting fees, $11,375,000 of deferred underwriting fees and $516,778 of other offering costs. On June 30, 2022, the underwriter waived its $11,375,000 deferred underwriting fee. As a result, the Company derecognized the deferred underwriting fee payable of $11,375,000 and recorded the forgiveness of the deferred underwriting fee allocated to Public Shares to the carrying value of the shares of Class A ordinary shares. Following the closing of the Initial Public Offering on January 12, 2021, an amount of $325,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the private placement warrants (the “Private Placement Warrants”) was placed in a trust account (the “Trust Account”), and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company, until the earliest of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (excluding the amount of deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders of the public shares (the “Public Shareholders” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of the Business Combination, either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially $10.00 per Public Share), including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, subject to certain limitations as described in the prospectus. The per-share amount to be distributed to the Public Shareholders who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, Prospector Sponsor LLC (the “Sponsor”) has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust Account, divided by the number of then issued and outstanding Public Shares. The Company had until January 12, 2023 to consummate a Business Combination. On January 5, 2023, the Company held an extraordinary general meeting in lieu of the annual general meeting of shareholders. In this meeting the shareholders approved amendments to the Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must complete a Business Combination from January 12, 2023 to December 31, 2023 (the “Combination Period”). In connection with this meeting, shareholders holding an aggregate of 30,305,944 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for $10.15 per share of the funds held in the Company’s Trust Account for total redemption amount of $307,620,347, leaving approximately $22.3 million in the Trust Account after such redemption. However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, in each case. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Capital Resources At September 30, 2023, the Company had $26,121 in its operating bank account and working capital deficit of $5,565,026. In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Convertible Promissory Note (see Note 5). At September 30, 2023 and December 31, 2022, there were amounts of $1,238,623 and $157,000 outstanding under Convertible Promissory Note–Related Party, respectively. Going Concern In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Update 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 31, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. Additionally, the Company may not have sufficient liquidity to fund the working capital needs of the Company through the Company’s liquidation date or one year from the issuance of these financial statements. Management intends to complete a Business Combination to alleviate any potential liquidity issues presented to the Company in its search to complete a Business Combination. If a Business Combination is not consummated by the liquidation date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution, raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 31, 2023. There can be no assurance that the Company will be able to consummate any Business Combination by December 31, 2023.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	9 Months Ended
	Sep. 30, 2023
Restatement of Previously Issued Financial Statements [Abstract]
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS In connection with the preparation of the Company’s condensed financial statements as of and for the period ended September 30, 2023, management identified an error in its previously filed Quarterly Reports on Form 10-Q for the periods ended March 31, 2023 and June 30, 2023 (the “Affected Quarterly Periods”). The Company determined that based on its review of its accounting treatment for Public and Private Placement Warrants (together, the “Warrants”) under ASC 815, as a result of the redemptions that occurred on January 24, 2023 in connection with the Company’s extraordinary general meeting to extend the date by which it must consummate an initial business combination, its accounting for the Warrants was incorrectly presented as part of equity and the Warrants should be instead presented as liabilities, with changes in value of such liabilities reported in earnings. The Company’s management determined that such redemptions resulted in the possibility for the tender offer provision contained in Section 4.4 of the warrant agreement, dated as of January 7, 2021, between the Company and Continental Stock Transfer & Trust Company (the “Warrant Agreement”), to be triggered without the requirement that a change in control also be triggered, which resulted in the determination that the Warrants no longer qualify for equity treatment. In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements”; the Company evaluated the changes and has determined that the related impact was material to previously presented financial statements and related omitted disclosures of the Affected Quarterly Periods. Therefore, the Company concluded that the Affected Quarterly Periods should be restated. As such, the Company is reporting these restatements to the Affected Quarterly Period in this Quarterly Report on Form 10-Q. The previously presented Affected Quarterly Periods should no longer be relied upon. The impact of the restatement on the Company’s unaudited condensed financial statements are reflected in the following tables: As Previously Adjustment As Restated Condensed Balance Sheet as of March 31, 2023 (unaudited) Warrant Liability $ — $ 1,440,000 $ 1,440,000 Total Liabilities $ 2,308,157 $ 1,440,000 $ 3,748,157 Accumulated deficit $ (2,113,505 ) $ (1,440,000 ) $ (3,553,505 ) Total Shareholders’ Deficit $ (2,112,692 ) $ (1,440,000 ) $ (3,552,692 ) Condensed Statement of Operations for the three months ended March 31, 2023 (unaudited) Change in fair value of warrant liability $ — $ 320,000 $ 320,000 Total other income (expense) $ 1,025,595 $ (320,000 ) $ 705,595 Net Income (loss) $ (160,390 ) $ (320,000 ) $ (480,390 ) Basic and diluted net loss per share, Class A ordinary shares $ (0.01 ) $ (0.02 ) $ (0.03 ) Basic and diluted net loss per share, Class B ordinary shares $ (0.01 ) $ (0.02 ) $ (0.03 ) Condensed Statement of Equity for the three months ended March 31, 2023 (unaudited) Net Income (loss) $ (160,390 ) $ (320,000 ) $ (480,390 ) Initial Classification of Warrant Liability $ — $ 1,120,000 $ 1,120,000 Accumulated deficit $ (2,113,505 ) $ (1,440,000 ) $ (3,553,505 ) Condensed Statement of Cash Flows for the three months ended March 31, 2023 (unaudited) Net Income (loss) $ (160,390 ) $ (320,000 ) $ (480,390 ) Change in fair value of warrant liability $ — $ 320,000 $ 320,000 Non-cash investing and financing activities: Initial classification of warrant liability $ — $ 1,120,000 $ 1,120,000 As Previously Adjustment As Restated Condensed Balance Sheet as of June 30, 2023 (unaudited) Warrant Liability $ — $ 1,920,000 $ 1,920,000 Total Liabilities $ 5,916,032 $ 1,920,000 $ 7,836,032 Accumulated deficit $ (5,768,759 ) $ (1,920,000 ) $ (7,688,759 ) Total Shareholders’ deficit $ (5,767,946 ) $ (1,920,000 ) $ (7,687,946 ) Condensed Statement of Operations for the three months ended June 30, 2023 (unaudited) Change in fair value of warrant liability $ — $ 480,000 $ 480,000 Total other income (expense) $ 273,447 $ (480,000 ) $ (206,553 ) Net Income (loss) $ (3,381,807 ) $ (480,000 ) $ (3,861,807 ) Basic and diluted net loss per share, Class A ordinary shares $ (0.33 ) $ (0.04 ) $ (0.37 ) Basic and diluted net loss per share, Class B ordinary shares $ (0.33 ) $ (0.04 ) $ (0.37 ) Condensed Statement of Operations for the six months ended June 30, 2023 (unaudited) Change in fair value of warrant liability $ — $ 800,000 $ 800,000 Total other income (expense) $ 1,299,042 $ (800,000 ) $ 499,042 Net Income (loss) $ (3,542,197 ) $ (800,000 ) $ (4,342,197 ) Basic and diluted net loss per share, Class A ordinary shares $ (0.25 ) $ (0.05 ) $ (0.30 ) Basic and diluted net loss per share, Class B ordinary shares $ (0.25 ) $ (0.05 ) $ (0.30 ) Condensed Statement of Equity for the three months ended June 30, 2023 (unaudited) Net Income (loss) $ (3,381,807 ) $ (480,000 ) $ (3,861,807 ) Accumulated deficit $ (5,768,759 ) $ (1,920,000 ) $ (7,688,759 ) Condensed Statement of Cash Flows for the six months ended June 30, 2023 (unaudited) Net Income (loss) $ (3,542,197 ) $ (800,000 ) $ (4,342,197 ) Change in fair value of warrant liability $ — $ 800,000 $ 800,000 Non-cash investing and financing activities: Initial classification of warrant liability $ — $ 1,120,000 $ 1,120,000 The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at March 30, 2023 and June 30, 2023 indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level March 30, June 30, Liabilities: Warrant Liabilities – Public Warrants 1 $ 975,000 $ 1,300,000 Warrant Liabilities – Private Warrants 2 $ 465,000 $ 620,000 Bifurcated Derivative 3 $ — — The Public Warrants are actively trading in the open market, as such they are classified as Level 1 due to the use of an observable market quote in an active market under the ticker PRSRW. The Private Placement Warrants are classified as Level 2 due to the use of an observable market quote for a similar asset in an active market.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with SEC on March 31, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022. Offering Costs Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Class A ordinary shares issued were initially charged to temporary equity and then accreted to ordinary shares subject to redemption upon the completion of the Initial Public Offering. Offering costs amounting to $18,391,778 were charged to temporary equity upon the completion of the Initial Public Offering. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at redemption value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in capital, to the extent available, and accumulated deficit. At September 30, 2023 and December 31, 2022, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 325,000,000 Less: Class A ordinary shares issuance costs (18,391,778 ) Plus: Accretion of carrying value to redemption value 18,391,778 Class A ordinary shares subject to possible redemption at December 31, 2021 325,000,000 Plus: Waiver of Class A shares issuance costs 11,375,000 Less: Accretion of carrying value to redemption value (6,591,266 ) Class A ordinary shares subject to possible redemption at December 31, 2022 329,783,734 Less: Redemption of ordinary shares (307,620,347 ) Plus: Accretion of carrying value to redemption value 1,587,560 Class A ordinary shares subject to possible redemption at September 30, 2023 $ 23,750,947 Warrants The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company accounts for the Public Warrants and Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Previously, the Private Placement Warrants did not meet the criteria for equity treatment and were recorded as liabilities. Accordingly, the Company classified the Private Placement Warrants as liabilities at their fair value and adjusted the Private Placement Warrants to fair value at each reporting period. This liability was subject to re-measurement at each balance sheet date until exercised, and any change in fair value was recognized in the condensed statements of operations. The Private Placement Warrants for periods where no observable traded price was available were valued using a modified Black-Scholes model. On June 30, 2021, the Company executed an agreement whereby the holders of the private warrants will not transfer their warrants to non-affiliated holders. Beginning June 30, 2021 and thereafter, the private warrants were considered to be indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15 and therefore qualify for equity treatment. In connection with the preparation of the condensed financial statements of the Company as of and for the period ended September 30, 2023, the Company’s management identified an error in its condensed financial statements for the periods ending March 31, 2023 and June 30, 2023. The Company determined that, based on its review of its accounting treatment under ASC 815 of the Warrants, as a result of the January 24, 2023 redemptions in connection with the Company’s extraordinary general meeting to extend the date by which it must consummate an initial business combination, its accounting for the Warrants was incorrectly presented as part of equity and the Warrants should be instead presented as liabilities, with changes in value of such liabilities reported in earnings. The Company’s management determined that such redemptions resulted in the possibility for the tender offer provision contained in Section 4.4 of the Warrant Agreement, to be triggered without the requirement that a change in control also be triggered, which resulted in the determination that the Warrants no longer qualify for equity treatment. Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and December 31, 2022, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from income (loss) per ordinary share as the redemption value approximates fair value. The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 16,500,000 Class A ordinary shares in the aggregate. At September 30, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss) $ 79,269 $ 293,546 $ 1,026,278 $ 256,570 $ (1,485,330 ) $ (2,484,052 ) $ 1,014,578 $ 253,645 Denominator: Basic and diluted weighted average shares outstanding 2,194,056 8,125,000 32,500,000 8,125,000 4,858,315 8,125,000 32,500,000 8,125,000 Basic and diluted net income (loss) per ordinary share $ 0.04 $ 0.04 $ 0.03 $ 0.03 $ (0.31 ) $ (0.31 ) $ 0.03 $ 0.03 (1) For the three and nine months ended September 30, 2023 and 2022, basic and diluted ordinary shares are the same as there are no non-redeemable securities that are dilutive to the Company’s shareholders. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operation and cash flows. Fair Value of Financial Instruments The Company utilizes ASC Topic 820 “Fair Value Measurement” to determine the relative fair value of financial instruments other than derivate financial instruments. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). Carrying values for prepaid, accounts payable and accrued expenses approximate fair value, primarily due to their short-term nature. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2023
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERING	NOTE 4. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 32,500,000 Units, which includes a partial exercise by the underwriters of their over-allotment option in the amount of 2,500,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 7).

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares and Private Placement Warrants On September 28, 2020, pursuant to a Securities Purchase Agreement, the Sponsor purchased 10,062,500 Class B ordinary shares (the “Founder Shares”) and 10,050,000 Private Placement Warrants for an aggregate purchase price of $10,075,000. On December 16, 2020, pursuant to the Securities Purchase Agreement Amendment, the Sponsor returned 2,875,000 Founder Shares and 2,300,000 Private Placement Warrants to the Company for $2,300,000. In January 2021, the Sponsor forfeited an additional 2,583,333 Private Placement Warrants for no consideration, resulting in 7,187,500 Founder Shares and 5,166,667 Private Placement Warrants outstanding. On January 7, 2021, the Company effected a 1:1.2 share capitalization of its Class B ordinary shares, resulting in an aggregate of 8,625,000 Founder Shares outstanding, all of which are held by the Sponsor. Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 500,000 Private Placement Warrants for an aggregate purchase price of $750,000, or $1.50 per Private Placement Warrant. The Founder Shares included an aggregate of up to 1,125,000 shares that were subject to forfeiture in the event that, and to the extent to which, the underwriters’ option to purchase additional Units was exercised, so that the number of Founder Shares would equal, on an as-converted basis, 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. As a result of the underwriters’ election to partially exercise their over-allotment option and the forfeiture of the remaining option, 500,000 Founder Shares were forfeited and there are now 8,125,000 Class B ordinary shares issued and outstanding. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earliest of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Administrative Services Agreement The Company entered into an agreement, commencing on January 7, 2021 through the earlier of the consummation of a Business Combination or the Company’s liquidation, to pay the Sponsor a monthly fee of $10,000 for office space, utilities, secretarial and administrative services. For the three and nine months ended September 30, 2023 and 2022, the Company incurred $30,000 and $90,000 in fees for these services, respectively. As of September 30, 2023 and December 31, 2022, $330,000 and $240,000, respectively, of such fees are included in accrued expenses in the accompanying condensed balance sheets. Promissory Note — Related Party On September 18, 2020, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) June 30, 2021 and (ii) the completion of the Initial Public Offering. The outstanding amount of $10,000 was repaid on January 22, 2021. Borrowings under the Promissory Note are no longer available. Advance from Sponsor On February 16, 2022, the Sponsor deposited $25,000 as an advance payment into the Company’s operating bank account to cover operating expenses. An additional $45,000 was deposited as an advance payment to the Company’s operating bank account on May 16, 2022. As of September 30, 2023, the full $70,000 of the advance has been repaid and no amounts remain outstanding. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2023 and December 31, 2022, there were no amounts outstanding under the Working Capital Loans. Convertible Promissory Notes On May 16, 2022, the Company entered into a convertible promissory note with the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $1,500,000 (the “Convertible Promissory Note”). The Convertible Promissory Note is non-interest bearing and due on the earlier of December 31, 2023 and the date on which the Company consummates its initial business combination. If the Company completes a business combination, it would repay such additional loaned amounts, without interest, upon consummation of the business combination. In the event that a business combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such additional loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such additional loans (if any) may be convertible into warrants, at a price of $1.50 per warrant at the option of the Sponsor. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. Except for the foregoing, the terms of such additional loans (if any) have not been determined and no written agreements exist with respect to such loans. If the Company fully draws down on the Convertible Promissory Note and requires additional funds for working capital purposes, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company such additional funds as may be required. The issuance of the Convertible Promissory Note was approved by the board of directors and the audit committee on May 16, 2022. The conversion feature included in the convertible note was analyzed under ASC 815. The conversion feature does not qualify for the exception from derivative. Accordingly, the conversion feature was required to be bifurcated. The fair value of the embedded derivative was deemed to have a zero value at issuance and as of September 30, 2023. As of September 30, 2023 and December 31, 2022, there were amounts of $1,238,623 and $157,000 outstanding under the Convertible Promissory Note-Related Party, respectively.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and current global conflicts and has concluded that while it is reasonably possible that these events could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration Rights Pursuant to a registration and shareholders rights agreement entered into on January 7, 2021, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans or Convertible Promissory Note (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans or Convertible Promissory Note) will have registration rights to require the Company to register a sale of any of the securities held by them. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $11,375,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In June 2022, the Company and the underwriters executed a waiver letter confirming the underwriter’s waiver of its deferred fee under the terms of the underwriting agreement. As a result, the Company derecognized $11,375,000 of the deferred underwriting commissions and recorded an adjustment to the carrying value of the shares of Class A ordinary shares subject to redemption. Business Combination Agreement On June 12, 2023, Prospector Capital Corp., a Cayman Islands exempted company, entered into a Business Combination Agreement (as the same may be amended, supplemented or otherwise modified from time to time, the “BCA”), with LeddarTech Inc., a corporation existing under the laws of Canada (“LeddarTech”), and LeddarTech Holdings Inc., a company incorporated under the laws of Canada and a wholly owned subsidiary of LeddarTech (“Newco”). LeddarTech, founded in 2007 and headquartered in Québec, Canada, is an automotive advanced driver assistance and autonomous driving software company that offers low-level sensor fusion and perception solutions. In its first ten years, LeddarTech focused its business on software and signal processing for smart sensing solutions. Commencing in 2022, LeddarTech began to focus its business on pure-play automotive software for low-level fusion and perception. The BCA and the transactions contemplated thereby were unanimously approved by the boards of directors of each of Prospector and LeddarTech. Financial Advisor Agreement On April 11, 2023, the Company engaged a financial advisor in connection with the proposed Business Combination with LeddarTech Inc. Payment is contingent on the on the close of a Business Combination at which point the Company agrees to pay the advisor $3,000,000 and out-of-pocket expenses not to exceed $250,000.

Shareholders_ Deficit

Shareholders’ Deficit	9 Months Ended
	Sep. 30, 2023
Shareholders’ Deficit [Abstract]
SHAREHOLDERS’ DEFICIT	NOTE 7. SHAREHOLDERS’ DEFICIT Preference Shares no Class A Ordinary Shares Class B Ordinary Shares Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 78.7% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

Warrants

Warrants	9 Months Ended
	Sep. 30, 2023
Warrants [Abstract]
WARRANTS	NOTE 8. WARRANTS Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) one year from the closing of the Initial Public Offering. The Public Warrants will expire five The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the Warrant Agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60 th Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00. ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company sends to the notice of redemption to the warrant holders (the “Reference Value”). If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00. ● in whole and not in part; ● at $0.10 per warrant ● upon not less than 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A ordinary shares except as otherwise described below; ● if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the Warrant Agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. On June 30, 2021, the Company executed an agreement whereby the holders of the private warrants will not transfer their warrants to non-affiliated holders. The private warrants were considered to be indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15. Therefore, the Public and Private Placement Warrants were accounted for as equity in the condensed balance sheets. The Company determined that, based on its review of its accounting treatment under ASC 815 of the Warrants, as a result of the January 24, 2023 redemptions in connection with the Company’s extraordinary general meeting to extend the date by which it must consummate an initial business combination, its accounting for the Warrants was incorrectly presented as part of equity for the quarters ended March 31, 2023 and June 30, 2023, and the Warrants should be instead presented as liabilities, with changes in value of such liabilities reported in earnings. The Company’s management determined that such redemptions resulted in the possibility for the tender offer provision contained in Section 4.4 of the Warrant Agreement, to be triggered without the requirement that a change in control also be triggered, which resulted in the determination that the Warrants no longer qualify for equity treatment.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2023
Fair Value Measurements [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 9. FAIR VALUE MEASUREMENTS The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320, “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts. Securities invested in money market funds are recorded based on quoted market prices in active market. At September 30, 2023, assets held in the Trust Account were comprised of $23,750,947 in money market funds which are invested primarily in U.S. Treasury Securities. Through September 30, 2023, the Company withdrew $307,620,347 from the Trust Account in connection with redemption. At December 31, 2022, assets held in the Trust Account were comprised of $329,783,734 in money market funds which are invested primarily in U.S. Treasury securities. Through December 31, 2022, the Company did not withdraw any interest income from the Trust Account. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, December 31, Assets: Investments held in Trust Account 1 $ 23,750,947 $ 329,783,734 Liabilities: Warrant Liabilities – Public Warrants 2 $ 541,667 $ — Warrant Liabilities – Private Warrants 2 $ 258,333 $ — Bifurcated Derivative 3 $ — n/a Measurement Warrants In connection with the preparation of the condensed financial statements of the Company The Public Warrants have limited trading activity in the open and observable market as of the measurement date, as such they are classified as Level 2. When the observable market quote under the ticker PRSRW is active, then Public Warrants are classified as Level 1. The Private Placement Warrants are classified as Level 2 due to the use of an observable market quote for a similar asset in an active market. Convertible Note Bifurcated Derivative The Company established the initial fair value for the Convertible Note Bifurcated Derivative as of January 26, 2023, which was the date the Convertible Note was executed. The Convertible Note Bifurcated Derivative was classified within Level 3 of the fair value hierarchy at the initial measurement dates and as of September 30, 2023 and January 26, 2023 due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation model for the Convertible Note Bifurcated Derivative were as follows at September 30, 2023 and January 26, 2023: January 26, September 30, Volatility 6.70 % 3.70 % Risk Free Rate 4.77 % 5.55 % Probability of completing a business combination by July 31, 2023 30 % — % Probability of completing a business combination by August 31, 2023 40 % — % Probability of completing a business combination by September 31, 2023 30 % — % Probability of completing a business combination by October 31, 2023 — % 10 % Probability of completing a business combination by November 30, 2023 — % 60 % Probability of completing a business combination by December 31, 2023 — % 30 % The following table presents the changes in the fair value of warrant liabilities and the bifurcated derivative for the period ended September 30, 2023: Private Public Bifurcated Warrants Warrants Derivative Initial value as of January 24, 2023 for warrants and January 26, 2023 for Bifurcated Derivative $ 361,667 $ 758,333 $ — Change in valuation inputs or other assumptions 103,333 216,667 — Fair value as of March 31, 2023 $ 465,000 $ 975,000 $ — Change in valuation inputs or other assumptions 155,000 325,000 — Fair value as of June 30, 2023 $ 620,000 $ 1,300,000 $ — Change in valuation inputs or other assumptions (361,667 ) (758,333 ) — Fair value as of September 30, 2023 $ 258,333 $ 541,667 $ — Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. There were no transfers between levels during the three and nine months ended September 30, 2023 and 2022.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with SEC on March 31, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.
Offering Costs	Offering Costs Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Class A ordinary shares issued were initially charged to temporary equity and then accreted to ordinary shares subject to redemption upon the completion of the Initial Public Offering. Offering costs amounting to $18,391,778 were charged to temporary equity upon the completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at redemption value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in capital, to the extent available, and accumulated deficit. At September 30, 2023 and December 31, 2022, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 325,000,000 Less: Class A ordinary shares issuance costs (18,391,778 ) Plus: Accretion of carrying value to redemption value 18,391,778 Class A ordinary shares subject to possible redemption at December 31, 2021 325,000,000 Plus: Waiver of Class A shares issuance costs 11,375,000 Less: Accretion of carrying value to redemption value (6,591,266 ) Class A ordinary shares subject to possible redemption at December 31, 2022 329,783,734 Less: Redemption of ordinary shares (307,620,347 ) Plus: Accretion of carrying value to redemption value 1,587,560 Class A ordinary shares subject to possible redemption at September 30, 2023 $ 23,750,947
Warrants	Warrants The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company accounts for the Public Warrants and Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Previously, the Private Placement Warrants did not meet the criteria for equity treatment and were recorded as liabilities. Accordingly, the Company classified the Private Placement Warrants as liabilities at their fair value and adjusted the Private Placement Warrants to fair value at each reporting period. This liability was subject to re-measurement at each balance sheet date until exercised, and any change in fair value was recognized in the condensed statements of operations. The Private Placement Warrants for periods where no observable traded price was available were valued using a modified Black-Scholes model. On June 30, 2021, the Company executed an agreement whereby the holders of the private warrants will not transfer their warrants to non-affiliated holders. Beginning June 30, 2021 and thereafter, the private warrants were considered to be indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15 and therefore qualify for equity treatment. In connection with the preparation of the condensed financial statements of the Company as of and for the period ended September 30, 2023, the Company’s management identified an error in its condensed financial statements for the periods ending March 31, 2023 and June 30, 2023. The Company determined that, based on its review of its accounting treatment under ASC 815 of the Warrants, as a result of the January 24, 2023 redemptions in connection with the Company’s extraordinary general meeting to extend the date by which it must consummate an initial business combination, its accounting for the Warrants was incorrectly presented as part of equity and the Warrants should be instead presented as liabilities, with changes in value of such liabilities reported in earnings. The Company’s management determined that such redemptions resulted in the possibility for the tender offer provision contained in Section 4.4 of the Warrant Agreement, to be triggered without the requirement that a change in control also be triggered, which resulted in the determination that the Warrants no longer qualify for equity treatment.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and December 31, 2022, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from income (loss) per ordinary share as the redemption value approximates fair value. The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 16,500,000 Class A ordinary shares in the aggregate. At September 30, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss) $ 79,269 $ 293,546 $ 1,026,278 $ 256,570 $ (1,485,330 ) $ (2,484,052 ) $ 1,014,578 $ 253,645 Denominator: Basic and diluted weighted average shares outstanding 2,194,056 8,125,000 32,500,000 8,125,000 4,858,315 8,125,000 32,500,000 8,125,000 Basic and diluted net income (loss) per ordinary share $ 0.04 $ 0.04 $ 0.03 $ 0.03 $ (0.31 ) $ (0.31 ) $ 0.03 $ 0.03 (1) For the three and nine months ended September 30, 2023 and 2022, basic and diluted ordinary shares are the same as there are no non-redeemable securities that are dilutive to the Company’s shareholders.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operation and cash flows.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company utilizes ASC Topic 820 “Fair Value Measurement” to determine the relative fair value of financial instruments other than derivate financial instruments. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). Carrying values for prepaid, accounts payable and accrued expenses approximate fair value, primarily due to their short-term nature. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	9 Months Ended
	Sep. 30, 2023
Restatement of Previously Issued Financial Statements [Abstract]
Schedule of unaudited condensed financial statements	The impact of the restatement on the Company’s unaudited condensed financial statements are reflected in the following tables: As Previously Adjustment As Restated Condensed Balance Sheet as of March 31, 2023 (unaudited) Warrant Liability $ — $ 1,440,000 $ 1,440,000 Total Liabilities $ 2,308,157 $ 1,440,000 $ 3,748,157 Accumulated deficit $ (2,113,505 ) $ (1,440,000 ) $ (3,553,505 ) Total Shareholders’ Deficit $ (2,112,692 ) $ (1,440,000 ) $ (3,552,692 ) Condensed Statement of Operations for the three months ended March 31, 2023 (unaudited) Change in fair value of warrant liability $ — $ 320,000 $ 320,000 Total other income (expense) $ 1,025,595 $ (320,000 ) $ 705,595 Net Income (loss) $ (160,390 ) $ (320,000 ) $ (480,390 ) Basic and diluted net loss per share, Class A ordinary shares $ (0.01 ) $ (0.02 ) $ (0.03 ) Basic and diluted net loss per share, Class B ordinary shares $ (0.01 ) $ (0.02 ) $ (0.03 ) Condensed Statement of Equity for the three months ended March 31, 2023 (unaudited) Net Income (loss) $ (160,390 ) $ (320,000 ) $ (480,390 ) Initial Classification of Warrant Liability $ — $ 1,120,000 $ 1,120,000 Accumulated deficit $ (2,113,505 ) $ (1,440,000 ) $ (3,553,505 ) Condensed Statement of Cash Flows for the three months ended March 31, 2023 (unaudited) Net Income (loss) $ (160,390 ) $ (320,000 ) $ (480,390 ) Change in fair value of warrant liability $ — $ 320,000 $ 320,000 Non-cash investing and financing activities: Initial classification of warrant liability $ — $ 1,120,000 $ 1,120,000 As Previously Adjustment As Restated Condensed Balance Sheet as of June 30, 2023 (unaudited) Warrant Liability $ — $ 1,920,000 $ 1,920,000 Total Liabilities $ 5,916,032 $ 1,920,000 $ 7,836,032 Accumulated deficit $ (5,768,759 ) $ (1,920,000 ) $ (7,688,759 ) Total Shareholders’ deficit $ (5,767,946 ) $ (1,920,000 ) $ (7,687,946 ) Condensed Statement of Operations for the three months ended June 30, 2023 (unaudited) Change in fair value of warrant liability $ — $ 480,000 $ 480,000 Total other income (expense) $ 273,447 $ (480,000 ) $ (206,553 ) Net Income (loss) $ (3,381,807 ) $ (480,000 ) $ (3,861,807 ) Basic and diluted net loss per share, Class A ordinary shares $ (0.33 ) $ (0.04 ) $ (0.37 ) Basic and diluted net loss per share, Class B ordinary shares $ (0.33 ) $ (0.04 ) $ (0.37 ) Condensed Statement of Operations for the six months ended June 30, 2023 (unaudited) Change in fair value of warrant liability $ — $ 800,000 $ 800,000 Total other income (expense) $ 1,299,042 $ (800,000 ) $ 499,042 Net Income (loss) $ (3,542,197 ) $ (800,000 ) $ (4,342,197 ) Basic and diluted net loss per share, Class A ordinary shares $ (0.25 ) $ (0.05 ) $ (0.30 ) Basic and diluted net loss per share, Class B ordinary shares $ (0.25 ) $ (0.05 ) $ (0.30 ) Condensed Statement of Equity for the three months ended June 30, 2023 (unaudited) Net Income (loss) $ (3,381,807 ) $ (480,000 ) $ (3,861,807 ) Accumulated deficit $ (5,768,759 ) $ (1,920,000 ) $ (7,688,759 ) Condensed Statement of Cash Flows for the six months ended June 30, 2023 (unaudited) Net Income (loss) $ (3,542,197 ) $ (800,000 ) $ (4,342,197 ) Change in fair value of warrant liability $ — $ 800,000 $ 800,000 Non-cash investing and financing activities: Initial classification of warrant liability $ — $ 1,120,000 $ 1,120,000
Schedule of Fair Value Liabilities Measured on Recurring Basis	The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at March 30, 2023 and June 30, 2023 indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level March 30, June 30, Liabilities: Warrant Liabilities – Public Warrants 1 $ 975,000 $ 1,300,000 Warrant Liabilities – Private Warrants 2 $ 465,000 $ 620,000 Bifurcated Derivative 3 $ — —

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]
Schedule of the Class A Ordinary Shares Reflected in the Balance Sheet	At September 30, 2023 and December 31, 2022, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 325,000,000 Less: Class A ordinary shares issuance costs (18,391,778 ) Plus: Accretion of carrying value to redemption value 18,391,778 Class A ordinary shares subject to possible redemption at December 31, 2021 325,000,000 Plus: Waiver of Class A shares issuance costs 11,375,000 Less: Accretion of carrying value to redemption value (6,591,266 ) Class A ordinary shares subject to possible redemption at December 31, 2022 329,783,734 Less: Redemption of ordinary shares (307,620,347 ) Plus: Accretion of carrying value to redemption value 1,587,560 Class A ordinary shares subject to possible redemption at September 30, 2023 $ 23,750,947
Schedule of Basic and Diluted Net Income (Loss) Per Ordinary Share	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss) $ 79,269 $ 293,546 $ 1,026,278 $ 256,570 $ (1,485,330 ) $ (2,484,052 ) $ 1,014,578 $ 253,645 Denominator: Basic and diluted weighted average shares outstanding 2,194,056 8,125,000 32,500,000 8,125,000 4,858,315 8,125,000 32,500,000 8,125,000 Basic and diluted net income (loss) per ordinary share $ 0.04 $ 0.04 $ 0.03 $ 0.03 $ (0.31 ) $ (0.31 ) $ 0.03 $ 0.03

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Measurements [Abstract]
Schedule of Assets and Liabilities that are Measured at Fair Value on A Recurring Basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, December 31, Assets: Investments held in Trust Account 1 $ 23,750,947 $ 329,783,734 Liabilities: Warrant Liabilities – Public Warrants 2 $ 541,667 $ — Warrant Liabilities – Private Warrants 2 $ 258,333 $ — Bifurcated Derivative 3 $ — n/a
Schedule of Classified Within Level 3 of the fair Value Hierarchy	The key inputs into the Monte Carlo simulation model for the Convertible Note Bifurcated Derivative were as follows at September 30, 2023 and January 26, 2023: January 26, September 30, Volatility 6.70 % 3.70 % Risk Free Rate 4.77 % 5.55 % Probability of completing a business combination by July 31, 2023 30 % — % Probability of completing a business combination by August 31, 2023 40 % — % Probability of completing a business combination by September 31, 2023 30 % — % Probability of completing a business combination by October 31, 2023 — % 10 % Probability of completing a business combination by November 30, 2023 — % 60 % Probability of completing a business combination by December 31, 2023 — % 30 %
Schedule of Fair Value of Warrant Liabilities and the Bifurcated	The following table presents the changes in the fair value of warrant liabilities and the bifurcated derivative for the period ended September 30, 2023: Private Public Bifurcated Warrants Warrants Derivative Initial value as of January 24, 2023 for warrants and January 26, 2023 for Bifurcated Derivative $ 361,667 $ 758,333 $ — Change in valuation inputs or other assumptions 103,333 216,667 — Fair value as of March 31, 2023 $ 465,000 $ 975,000 $ — Change in valuation inputs or other assumptions 155,000 325,000 — Fair value as of June 30, 2023 $ 620,000 $ 1,300,000 $ — Change in valuation inputs or other assumptions (361,667 ) (758,333 ) — Fair value as of September 30, 2023 $ 258,333 $ 541,667 $ —

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)		9 Months Ended	12 Months Ended
	Jan. 12, 2021	Sep. 30, 2023	Dec. 31, 2021	Dec. 31, 2022
Description of Organization and Business Operations [Line Items]
Shares of initial public offering (in Shares)	32,500,000
Amount of gross proceeds	$ 325,000,000
Transaction costs		$ 18,391,778
Amount of underwriting fees		6,500,000
Deferred underwriting fees		11,375,000
Other offering costs		516,778
Underwriting fee		11,375,000
Underwriting fee payable		$ 11,375,000
Net proceeds amount			$ 325,000,000
Fair value market, percentage		80%
Public share price per share (in Dollars per share)		$ 10
Net tangible assets		$ 5,000,001
Public shares, percentage		15%
Percentage of business combination redeemed shares		100%
Shareholders holding (in Shares)		30,305,944
Ordinary per share (in Dollars per share)		$ 10.15
Trust account		$ 307,620,347
Trust account redemption value		$ 22,300,000
Percentage of public share		100%
Interest payable		$ 100,000
Description of prospective target business		In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, in each case. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
Operating bank accounts		$ 26,121
Working capital deficit		5,565,026
Convertible promissory notes		$ 1,238,623		$ 157,000
Over-Allotment Option [Member]
Description of Organization and Business Operations [Line Items]
Shares issued (in Shares)	2,500,000
Share price (in Dollars per share)	$ 10
Public shares price (in Dollars per share)		$ 10
IPO [Member]
Description of Organization and Business Operations [Line Items]
Share price (in Dollars per share)	$ 10	10
Net proceeds amount	$ 325,000,000
Sponsor [Member]
Description of Organization and Business Operations [Line Items]
Price per public shares (in Dollars per share)		10
Public shares price (in Dollars per share)		$ 10
Post Business Combination [Member]
Description of Organization and Business Operations [Line Items]
Business combination percentage		50%

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Details) - Schedule of unaudited condensed financial statements - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2023
Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liability
Total Liabilities	5,916,032	2,308,157	5,916,032
Accumulated deficit	(5,768,759)	(2,113,505)	(5,768,759)
Total Shareholders’ Deficit	(5,767,946)	(2,112,692)	(5,767,946)
Change in fair value of warrant liability
Non-cash investing and financing activities:
Total other income (expense)	273,447	1,025,595	1,299,042
Net Income (loss)	$ (3,381,807)	(160,390)	(3,542,197)
Initial Classification of Warrant Liability
Basic and diluted net loss per share, Class A ordinary shares (in Dollars per share)	$ (0.33)	$ (0.01)	$ (0.25)
Basic and diluted net loss per share, Class B ordinary shares (in Dollars per share)	$ (0.33)	$ (0.01)	$ (0.25)
Adjustment [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liability	$ 1,920,000	$ 1,440,000	$ 1,920,000
Total Liabilities	1,920,000	1,440,000	1,920,000
Accumulated deficit	(1,920,000)	(1,440,000)	(1,920,000)
Total Shareholders’ Deficit	(1,920,000)	(1,440,000)	(1,920,000)
Change in fair value of warrant liability	480,000	320,000	800,000
Non-cash investing and financing activities:
Total other income (expense)	(480,000)	(320,000)	(800,000)
Net Income (loss)	$ (480,000)	(320,000)	(800,000)
Initial Classification of Warrant Liability		$ 1,120,000	$ 1,120,000
Basic and diluted net loss per share, Class A ordinary shares (in Dollars per share)	$ (0.04)	$ (0.02)	$ (0.05)
Basic and diluted net loss per share, Class B ordinary shares (in Dollars per share)	$ (0.04)	$ (0.02)	$ (0.05)
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liability	$ 1,920,000	$ 1,440,000	$ 1,920,000
Total Liabilities	7,836,032	3,748,157	7,836,032
Accumulated deficit	(7,688,759)	(3,553,505)	(7,688,759)
Total Shareholders’ Deficit	(7,687,946)	(3,552,692)	(7,687,946)
Change in fair value of warrant liability	480,000	320,000	800,000
Non-cash investing and financing activities:
Total other income (expense)	(206,553)	705,595	499,042
Net Income (loss)	$ (3,861,807)	(480,390)	(4,342,197)
Initial Classification of Warrant Liability		$ 1,120,000	$ 1,120,000
Basic and diluted net loss per share, Class A ordinary shares (in Dollars per share)	$ (0.37)	$ (0.03)	$ (0.3)
Basic and diluted net loss per share, Class B ordinary shares (in Dollars per share)	$ (0.37)	$ (0.03)	$ (0.3)

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements (Details) - Schedule of Fair Value Liabilities Measured on Recurring Basis - Warrant [Member] - USD ($)	Jun. 30, 2023	Mar. 31, 2023
Schedule of Fair Value Liabilities Measured on Recurring Basis [Line Items]
Bifurcated Derivative
Public Warrants [Member]
Schedule of Fair Value Liabilities Measured on Recurring Basis [Line Items]
Warrant Liabilities	1,300,000	975,000
Private Warrants [Member]
Schedule of Fair Value Liabilities Measured on Recurring Basis [Line Items]
Warrant Liabilities	$ 620,000	$ 465,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2023 USD ($) shares
Significant Accounting Policies [Line Items]
Offering costs	$ 18,391,778
Federal deposit insurance corporation coverage limit	$ 250,000
Class A Ordinary Shares [Member]
Significant Accounting Policies [Line Items]
Aggregate shares (in Shares) | shares	16,500,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of the Class A Ordinary Shares Reflected in the Balance Sheet - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of the Class A Ordinary Shares Reflected in the Balance Sheet [Abstract]
Gross proceeds			$ 325,000,000
Less:
Class A ordinary shares issuance costs			(18,391,778)
Plus:
Accretion of carrying value to redemption value	$ 1,587,560	$ (6,591,266)	18,391,778
Class A ordinary shares subject to possible redemption	23,750,947	329,783,734	$ 325,000,000
Less:
Redemption of ordinary shares	$ (307,620,347)
Plus:
Waiver of Class A shares issuance costs		$ 11,375,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Ordinary Share - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Class A [Member]
Numerator:
Allocation of net income (loss)	$ 79,269	$ 1,026,278	$ (1,485,330)	$ 1,014,578
Denominator:
Basic and diluted weighted average shares outstanding	2,194,056	32,500,000	4,858,315	32,500,000
Basic and diluted net income (loss) per ordinary share	$ 0.04	$ 0.03	$ (0.31)	$ 0.03
Class B [Member]
Numerator:
Allocation of net income (loss)	$ 293,546	$ 256,570	$ (2,484,052)	$ 253,645
Denominator:
Basic and diluted weighted average shares outstanding	8,125,000	8,125,000	8,125,000	8,125,000
Basic and diluted net income (loss) per ordinary share	$ 0.04	$ 0.03	$ (0.31)	$ 0.03

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Ordinary Share (Parentheticals) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Class A [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Ordinary Share (Parentheticals) [Line Items]
Diluted weighted average shares outstanding	2,194,056	32,500,000	4,858,315	32,500,000
Diluted net income (loss) per ordinary share	$ 0.04	$ 0.03	$ (0.31)	$ 0.03
Class B [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Ordinary Share (Parentheticals) [Line Items]
Diluted weighted average shares outstanding	8,125,000	8,125,000	8,125,000	8,125,000
Diluted net income (loss) per ordinary share	$ 0.04	$ 0.03	$ (0.31)	$ 0.03

Initial Public Offering (Detail

Initial Public Offering (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Initial Public Offering [Line Items]
Number of shares in a unit	1
IPO [Member]
Initial Public Offering [Line Items]
Sale of stock	32,500,000
Over-Allotment Option [Member]
Initial Public Offering [Line Items]
Sale of stock	2,500,000
Exercise price (in Dollars per share) | $ / shares	$ 10
Warrant [Member]
Initial Public Offering [Line Items]
Number of shares issuable per warrant	1
Warrant [Member] | IPO [Member]
Initial Public Offering [Line Items]
Number of warrants in a unit	1
Warrant [Member] | Class A Ordinary Shares [Member] | IPO [Member]
Initial Public Offering [Line Items]
(in Dollars per share) | $ / shares	$ 11.5

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Feb. 16, 2022

Jan. 07, 2021

May 16, 2022

Jan. 31, 2021

Jan. 22, 2021

Dec. 16, 2020

Sep. 28, 2020

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Sep. 18, 2020

Related Party Transactions [Line Items]

Private placement warrants, shares (in Shares)

2,300,000

Aggregate purchase price

$ 10,075,000

Sponsor returned founder shares (in Shares)

2,875,000

Private placement warrants amount

$ 2,300,000

Securities purchase agreement description

On January 7, 2021, the Company effected a 1:1.2 share capitalization of its Class B ordinary shares, resulting in an aggregate of 8,625,000 Founder Shares outstanding, all of which are held by the Sponsor.

Aggregate purchased share (in Shares)

500,000

Aggregate purchase amount

$ 750,000

Aggregate purchase price per share (in Dollars per share)

$ 1.5

Subject forfeiture share (in Shares)

1,125,000

Percentage of issued and outstanding

20%

Warrant exercisable, description

Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8).

Exceeds price (in Dollars per share)

$ 12

Sponsor amount

$ 10,000

Fee amount

$ 30,000

$ 90,000

$ 30,000

$ 90,000

Aggregate fees

330,000

$ 240,000

Aggregate principal amount

$ 300,000

Outstanding amount

$ 10,000

1,238,623

$ 157,000

Sponsor deposits

$ 25,000

Advance payment

$ 45,000

Advance from sponsor

70,000

Working capital loans

$ 1,500,000

Aggregate principal amount

1,500,000

Additional loans

$ 1,500,000

Warrant price per share (in Dollars per share)

$ 1.5

Private Placement Warrants [Member]

Related Party Transactions [Line Items]

Private placement warrants, shares (in Shares)

10,050,000

Class B Ordinary Shares [Member] | Founder Shares [Member]

Related Party Transactions [Line Items]

Aggregate purchased shares (in Shares)

10,062,500

Remaining option description

As a result of the underwriters’ election to partially exercise their over-allotment option and the forfeiture of the remaining option, 500,000 Founder Shares were forfeited and there are now 8,125,000 Class B ordinary shares issued and outstanding.

Private placement warrants [Member]

Related Party Transactions [Line Items]

Shares issued (in Shares)

2,583,333

Private Placement Warrants Outstanding [Member]

Related Party Transactions [Line Items]

Shares issued (in Shares)

5,166,667

Post-Business Combination [Member]

Related Party Transactions [Line Items]

Business combination entity at a price per warrant (in Dollars per share)

$ 1.5

$ 1.5

Sponsor [Member]

Related Party Transactions [Line Items]

Shares issued (in Shares)

7,187,500

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)		9 Months Ended
	Apr. 11, 2023	Sep. 30, 2023
Commitments and Contingencies [Line Items]
Deferred fee, per unit (in Dollars per share)		$ 0.35
Deferred underwriting fees		$ 11,375,000
Company recognized benefit		$ 11,375,000
Advisor amount	$ 3,000,000
Exceed expenses	$ 250,000

Shareholders_ Deficit (Details)

Shareholders’ Deficit (Details) - $ / shares	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Shareholders’ Deficit [Line Items]
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares issued
Preference shares, shares outstanding
Percentage of total number	78.70%
Class A Ordinary Shares [Member]
Shareholders’ Deficit [Line Items]
Common stock, shares authorized	200,000,000	200,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued	2,194,056	32,500,000
Common stock, shares outstanding	2,194,056	32,500,000
Class B Ordinary Shares [Member]
Shareholders’ Deficit [Line Items]
Common stock, shares authorized	20,000,000	20,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued	8,125,000	8,125,000
Common stock, shares outstanding	8,125,000	8,125,000

Warrants (Details)

Warrants (Details)	9 Months Ended
	Sep. 30, 2023
Warrant Liabilities [Line Items]
Public warrants expire term	5 years
Redemption of outstanding warrants, description	Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants:   ● in whole and not in part;         ● at $0.10 per warrant         ● upon not less than 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A ordinary shares except as otherwise described below;         ● if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and         ● if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
Business combination, description	In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
Warrant [Member]
Warrant Liabilities [Line Items]
Redemption of warrants, description	Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00. Once the warrants become exercisable, the Company may call the warrants for redemption (except as described with respect to the Private Placement Warrants):   ● in whole and not in part;         ● at a price of $0.01 per warrant;         ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and         ● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company sends to the notice of redemption to the warrant holders (the “Reference Value”).   If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Fair Value Measurements [Abstract]
Assets held in trust account	$ 23,750,947	$ 329,783,734
Interest income from the Trust Account	$ 307,620,347

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of Assets and Liabilities that are Measured at Fair Value on A Recurring Basis - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Level 1 [Member]
Schedule of Assets and Liabilities that are Measured at Fair Value on A Recurring Basis [Line Items]
Investments held in Trust Account	$ 23,750,947	$ 329,783,734
Level 2 [Member] | Public Warrants [Member]
Schedule of Assets and Liabilities that are Measured at Fair Value on A Recurring Basis [Line Items]
Warrant Liabilities – Public Warrants	541,667
Level 2 [Member] | Private Warrants [Member]
Schedule of Assets and Liabilities that are Measured at Fair Value on A Recurring Basis [Line Items]
Warrant Liabilities – Public Warrants	258,333
Level 3 [Member]
Schedule of Assets and Liabilities that are Measured at Fair Value on A Recurring Basis [Line Items]
Bifurcated Derivative

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of Classified Within Level 3 of the fair Value Hierarchy		9 Months Ended
	Jan. 26, 2023	Sep. 30, 2023
Schedule of Classified Within Level 3 of the fair Value Hierarchy [Line Items]
Volatility	6.70%	3.70%
Risk Free Rate	4.77%	5.55%
July Thirty First Two Thousand Twenty Three [Member]
Schedule of Classified Within Level 3 of the fair Value Hierarchy [Line Items]
Probability of completing a business combination by	30%
August Thirty First Two Thousand Twenty Three [Member]
Schedule of Classified Within Level 3 of the fair Value Hierarchy [Line Items]
Probability of completing a business combination by	40%
September Thirty First Two Thousand Twenty Three [Member]
Schedule of Classified Within Level 3 of the fair Value Hierarchy [Line Items]
Probability of completing a business combination by	30%
October Thirty First Two Thousand Twenty Three [Member]
Schedule of Classified Within Level 3 of the fair Value Hierarchy [Line Items]
Probability of completing a business combination by		10%
November Thirty First Two Thousand Twenty Three [Member]
Schedule of Classified Within Level 3 of the fair Value Hierarchy [Line Items]
Probability of completing a business combination by		60%
December Thirty First Two Thousand Twenty Three [Member]
Schedule of Classified Within Level 3 of the fair Value Hierarchy [Line Items]
Probability of completing a business combination by		30%

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of Fair Value of Warrant Liabilities and the Bifurcated - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2023	Sep. 30, 2023	Jun. 30, 2023
Private Warrants [Member]
Schedule of Fair Value of Warrant Liabilities and the Bifurcated [Abstract]
Initial value as of January 24, 2023 for warrants and January 26, 2023 for Bifurcated Derivative	$ 361,667	$ 620,000	$ 465,000
Change in valuation inputs or other assumptions	103,333	(361,667)	155,000
Fair value as of	465,000	258,333	620,000
Public Warrants [Member]
Schedule of Fair Value of Warrant Liabilities and the Bifurcated [Abstract]
Initial value as of January 24, 2023 for warrants and January 26, 2023 for Bifurcated Derivative	758,333	1,300,000	975,000
Change in valuation inputs or other assumptions	216,667	(758,333)	325,000
Fair value as of	975,000	541,667	1,300,000
Bifurcated Derivative [Member]
Schedule of Fair Value of Warrant Liabilities and the Bifurcated [Abstract]
Initial value as of January 24, 2023 for warrants and January 26, 2023 for Bifurcated Derivative
Change in valuation inputs or other assumptions
Fair value as of